Craniopharyngioma

2 trials MedDRA PT
2 Registered trials
0 Recruiting
2 Unique sponsors
2 Unique IMPs
0 Commercial trials
Drug classes (ATC)
ATC code not specified 1
A Gastroenterology (ATC A) 1
Mechanism of action (INN-stem analysis)
RAF/BRAF inhibitor 1 substance
GLP-1 receptor agonist 1 substance
Phase III: 1 Phase II: 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase III

1 trial
  • Centre Hospitalier Universitaire D'Angers Academic
    SEMAGLUTIDE
    2024-511114-20-00 1 country n=50
    Pending

Phase II

1 trial
  • Prinses Maxima Centrum voor Kinderoncologie B.V. Academic
    TOVORAFENIB
    2024-511510-20-00 3 countries n=16 Orphan
    Pending
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Prinses Maxima Centrum voor Kinderoncologie B.V. Academic 1 Phase II 0
Centre Hospitalier Universitaire D'Angers Academic 1 Phase III 0
← All indication landscapes